KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to -$63.4 million.

  • Precigen's Cash from Investing Activities fell 122128.07% to -$63.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$106.8 million, marking a year-over-year decrease of 28425.43%. This contributed to the annual value of -$20.7 million for FY2024, which is 57100.75% down from last year.
  • Precigen's Cash from Investing Activities amounted to -$63.4 million in Q3 2025, which was down 122128.07% from $28.4 million recorded in Q2 2025.
  • Precigen's Cash from Investing Activities' 5-year high stood at $181.9 million during Q3 2022, with a 5-year trough of -$129.1 million in Q1 2021.
  • Over the past 5 years, Precigen's median Cash from Investing Activities value was $15.0 million (recorded in 2024), while the average stood at $4.6 million.
  • As far as peak fluctuations go, Precigen's Cash from Investing Activities surged by 1206187.85% in 2021, and later crashed by 122128.07% in 2025.
  • Quarter analysis of 5 years shows Precigen's Cash from Investing Activities stood at $15.9 million in 2021, then decreased by 28.3% to $11.4 million in 2022, then grew by 16.39% to $13.3 million in 2023, then plummeted by 591.74% to -$65.4 million in 2024, then increased by 3.03% to -$63.4 million in 2025.
  • Its Cash from Investing Activities was -$63.4 million in Q3 2025, compared to $28.4 million in Q2 2025 and -$6.5 million in Q1 2025.